The increasing prevalence of chronic wounds and availability of reimbursement for skin grafting are driving the global skin graft market growth at a CAGR of 6.59% during the forecast period 2025 to 2035

Market Research Future (MRFR) has published a cooked research report on the “Global Skin Graft Market” that contains information from 2019 to 2035.

The Global Skin Graft Market is estimated to register a CAGR of 6.59% during the forecast period of 2025 to 2035.

MRFR recognizes the following companies as the key players in the Global Skin Graft Market—B. Braun Se, Zimmer Biomet Holdings Inc, Integra Lifesciences Holdings Corporation, De Soutter Medical, Shaanxi XINGMAO Industry Co. Ltd, Aygün, Paramount SURGIMED Ltd, RIBBEL International Limited, Novo Surgical Inc, SURTEX Instruments and among others.

Market Highlights

The Global Skin Graft Market is estimated to register a CAGR of 6.59% during the forecast period and is estimated to reach USD 2.79 Billion by 2035.

The increasing prevalence of chronic wounds is a significant factor driving the growth of the skin graft market. Chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, are persistent wounds that fail to heal within the expected timeframe, often lasting for weeks or months. The global rise in conditions like diabetes, obesity, and vascular diseases has contributed to a higher incidence of these wounds. For example, according to the International Diabetes Federation, approximately 463 million adults worldwide suffer from diabetes, a primary risk factor for developing foot ulcers. 

These wounds often require advanced treatment options, including skin grafts, to promote healing and prevent complications such as infections or amputations. Skin grafts, including autografts, allografts, and xenografts, provide essential coverage for large or non-healing wounds by promoting tissue regeneration. The demand for these procedures has surged as healthcare providers seek effective solutions to manage chronic wounds efficiently. Additionally, technological advancements in skin graft materials, such as bioengineered and stem cell-based grafts, have improved healing outcomes, further fueling market growth.

Segment Analysis

The Global Skin Graft Market has been segmented based By Graft Type, By Product Type, By Application, and By End User.

Based on graft type, the global skin graft market has been segmented into autograft, allograft, and xenograft. The Autograft segment held the largest market share in 2024 and is the fastest-growing segment during the forecast period.

The Autograft segment accounted for the largest share of the global skin graft market in 2024 and is projected to witness the fastest growth over the forecast period. This dominance is attributed to its high effectiveness, lower risk of immune rejection, and improved graft survival rates, as the tissue is sourced from the patient’s own body. Autografts are widely used in treating extensive burns, chronic wounds, and surgical reconstruction due to their superior healing outcomes and reduced infection risks. Technological advancements in graft harvesting techniques and increasing adoption in both developed and emerging healthcare systems are further propelling the segment’s growth.

Based on product type, the global skin graft market has been segmented into dermatome, wound debridement device, and others. Further, dermatome segment is segmented into dermatome, powered dermatome, and drum and knife dermatome. The dermatome segment held the largest market share in 2024 and is the fastest-growing segment during the forecast period.

The Dermatome segment dominated the global skin graft market in 2024 and is expected to maintain the highest growth rate during the forecast period. Dermatomes, particularly powered and drum & knife variants, are essential surgical tools used for harvesting consistent and precise skin grafts. Their widespread adoption is driven by the rising number of burn and trauma cases, advancements in surgical technologies, and the growing demand for minimally invasive grafting procedures. The improved accuracy, efficiency, and reduced donor site morbidity offered by powered dermatomes are significantly contributing to the segment's rapid growth.

Based on Application, the global skin graft market has been segmented into pressure & venous ulcers, diabetes foot ulcers, burns, surgical wounds, and others. The burns segment held the largest market share in 2024, and diabetes foot ulcers is the fastest-growing segment during the forecast period.

The Burns segment held the largest share of the global skin graft market in 2024, driven by the high incidence of burn injuries worldwide and the critical need for effective wound coverage solutions. Skin grafting remains a primary treatment for severe burns to promote healing, reduce infection risks, and improve functional and cosmetic outcomes. The growing number of burn-related hospital admissions, particularly in low- and middle-income countries, along with increased awareness and advancements in grafting techniques, continue to support the segment’s dominance in the market.

Based on end user, the global skin graft market has been segmented into hospitals, ambulatory surgery centers, and specialty centers. The hospitals segment held the largest market share in 2024, and ambulatory surgery centers is the fastest-growing segment during the forecast period.

The Hospitals segment accounted for the largest share of the global skin graft market in 2024, owing to the high volume of burn, trauma, and surgical wound treatments conducted in these settings. Hospitals are typically equipped with advanced infrastructure, skilled healthcare professionals, and specialized burn and wound care units, making them the primary choice for complex skin graft procedures. Additionally, increased healthcare expenditure, improved reimbursement policies, and the availability of multidisciplinary care teams contribute to the segment's continued dominance in the market.

Regional Analysis

Based on region, the Global Skin Graft Market has been segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounted for the largest market share in 2024. However, Asia-Pacific is projected to grow at the highest CAGR during the forecast period.

Major demand factors driving the North America market are North America held the largest share of the global skin graft market in 2024, primarily driven by the high prevalence of burn injuries, chronic wounds, and diabetes-related complications. The presence of advanced healthcare infrastructure, strong adoption of innovative grafting technologies, and favorable reimbursement policies contribute significantly to regional market growth. The United States, in particular, leads the market due to increased surgical procedures, rising awareness about wound care management, and higher healthcare spending. Moreover, the growing geriatric population and rising cases of skin disorders further support the strong demand for skin grafts across the region.

Key Findings of the Study

• The Global Skin Graft Market is expected to reach USD 2.79 Billion by 2035, at a CAGR of 6.59% during the forecast period.


• The Asia Pacific region accounted for the fastest growing region in the global market.


• Based on Application, the Burns segment was attributed to holding the largest market in 2024.


• Braun Se, Zimmer Biomet Holdings Inc, Integra Lifesciences Holdings Corporation, De Soutter Medical, Shaanxi XINGMAO Industry Co. Ltd, Aygün, Paramount SURGIMED Ltd, RIBBEL International Limited, Novo Surgical Inc, SURTEX Instruments and among others are the key market players.